2012
6/29 Thomas Hillen, M.D., Professor, Graduate Chair, Department of Mathematical and Statistical Sciences/University of Alberta, Modelling of cell movement in tissue and application to glioma growth
6/14 Uwe Rix, Ph.D. Assistant Member, Drug Discovery/Moffitt, Systems pharmacology approaches for the dissection and prediction of drug action
5/21 James A. Glazier, Professor, DBiocomplexity Institute and Department of Physics, Indiana University, Applying multi-scale, multi cell modeling of pathological neovascularization in the retina and solid tumors to suggest novel treatment strategies PS-OC/IMO Seminar
5/16 Muhammad H. Zaman, Ph.D. Assistant Professor, Department of Biomedical Engineering and Medicine, Boston University, Quantiative systems level understanding of tumor cell-matrix interactions in 3 D environments PS-OC/IMO Seminar
4/27 Mark Lloyd, Core Staff Scientist, Analytic Microscopy/Moffitt, Eduardo Moros, Senior Member and Chief of Medical Physics, Moffitt, Imag(in)e the possibilities
3/8 Prakash Chinnayan, Ph.D., Assistant Member, Radiation Oncology/Moffitt. TBA
2/2 Philip Gerlee, Ph.D. Post Doc, Cancer Center Sahlgrenska and Mathematical Sciences, Gothenburg University and Chalmers The impact of phenotypic switching on glioblastoma growth and invasion
1/30 Joao Xavier, Ph.D. Assistant Faculty Member, Computational Biology, Memorial Sloan Cancer Center Robustness in multicellularity PS-OC/IMO Seminar
Previous IMO Weekly Seminars
2011
11/21 Katie Bentley, Ph.D., Vascular Biology Lab, Cancer Research UK, Time to branch? Simulations uncover new temporal and spatial dynamics of tip cells in angiogenesis
Vascular Biology Lab, Cancer Research UK,
11/18 Miguel Herrero, Ph.D. Professor, Department of Applied Mathematics University of Complutense de Madrid Optimization Problems in Radiotherapy Dosimetry Planning
10/13 Ziv Frankenstein Ph.D., Weizmann Institute of Science (IMO Post Doc Candidate) The cytokine network architecture of intercellular communication
9/8 Melvyn S. Tockman, MD, Ph.D. Moffitt, Senior Member, Research Looking at the Tumor's Edge
6/23 Irakli Loladze, Ph.D., Arizona State University (IMO Post Doc Candidate) Growth Rate and Stoichiometric Homeostasis in Cells and Ecosystems: An Evolutionary Model based on Biomolecular Synthesis
6/22 Michael W. Conroy, Ph.D., University of South Florida (IMO Post Doc Candidate) Models of Liquid Loss and Non-Newtonian Flow for Firefighting High-Expansion Aqueous Foams
6/20 Jayant Avva, Ph.D., Case Western Reserve University, (IMO Post Doc Candidate) A Methodology for Dynamic Expression Profile Extraction from Cytometry Data
6/16 Mun Ju Kim,Ph.D., University of Pittsburgh (IMO Post Doc Candidate) Computational Models of T-Cell Killing Apparatus Aim Adjustment
5/16 Marcus Owen, Ph.D., The University of Nottingham Mathematical Modeling Predicts Synergistic Benefits of Combining a Macrophage-Based Therapy with Chemotherapy
5/12 Steven A. Eschrich, Ph.D., Moffitt Genes, Proteins and Networks: Molecular Analysis in Translational Research
5/5 David Axelrod, Ph.D., Rutgers University Stem Cell Dynamics in Normal Human Colon Crypts and the Progression to Colon Cancer PS-OC/IMO Seminar
4/22 Timothy W. Secomb, Ph.D., University of Arizona Growth and Structural Adaptation of Microcirculation in Normal and Tumor Tissues PS-OC/IMO Seminar
4/7 Leonid A. Mirny, Ph.D., M.I.T. On Drivers and Passengers: A New Evolutionary Model of Cancer Progression PS-OC/IMO Seminar
3/24 Steve S. Brem, M.D., Moffitt Developing Treatments of Malignant Gliomas Using Inhibitors of Angiogenesis and Invasion: Potential Rose for Integrated Mathematical Modeling
3/7 Heiko Enderling, Ph.D. Tufts University School of Medicine Modeling the Cancer Stem Cell Hypothesis and Implications for Treatment IMO-PSOC Seminar
2/24 Alvaro Monteiro, Ph.D., Moffitt Probing the DNA Damage Response Using Networks
2/14 Eric A Mellon, Ph.D., University of Pennsylvania In Vivo NMR Spectroscopy of dfficult to detect metabolites
2/3 Conor Lynch,Ph.D., Moffitt Mechanisms of Cell-Cell Interaction in the Metastatic Prostate-Tumor Bone Microenvironment
1/27 Paul Orlando, The University of Illinois at Chicago Evolutionary Ecology of HPV: Tradeoffs, Co-Existence, and Species Origins of High-Risked and Low-Risk Types IMO-PSOC Seminar
2010
12/9 Srikumar Chellappan, Ph.D., ;Moffitt, Novels Insights into Lung Cancer Stem-Like Cells, Angiogenesis and Metastasis
11/18 Prakash Chinnaiyan, M.D.,;Moffitt, Targeting the Unfolded Protein Response (UPR) in Cancer: A Common Denominator of Unregulated Cellular Growth
10/25 Timothy Newman, Ph.D.,;Arizona State University, Cancer Is Complex - But Is It Simple? IMO-PSOC Seminar
10/14 Michael Tomblyn, M.D., MS,;Moffitt, Dosimetric Challenges for Delivery of Intrathecal Radioim
10/7 Jill Gallaher,Ph.D., IMO Post Doc Candidate, Pore Kinetics of Pure Lipid Bilayer Membranes at the Melting Transition
9/23 Shengyu Yang, Ph.D., Moffitt, Critical Roles of Actin Cytoskeleton in Cancer Metastasis
9/20 Hongfei Wu,Ph.D., IMO Post Doc Candidate, Stability of Viscoelastic Drop to Finite Perturbation/Multi-scale Simulation of Droplets on Solid Surfaces
9/17 Hugo Aerts,Ph.D.,University of Maastricht, Identification of the Radioresistant Areas Within the Tumor: Towards Dose Painting by Volumes
9/16 Amlan Chakraborty,Ph.D.,IMO Post Doc Candidate, Effects of Bidirectional Ocillatory Shear Stress on Endothelial Cell Proliferation, Morphology and Atherogenic Gene Expressions
8/26 Haley Jane Abel,Ph.D.,University of Utah, Estimating Linkage Disequilibrium by Graphical Modeling
6/24 Fang Yin, Ph.D.,IMO Postdoc Candidate, Polymer Loop Brush Simulation Study Using Monte-Carlo and Molecular Dynamics
6/15 Kieran Smallbone, D.Phil,Manchester Centre for Integrative Systems Biology, Cancelled
6/10 Trachette Jackson, Ph.D.,University of Michigan, Endothelial Cell-Targeted Anti-Cancer Therapies IMO-PSOC Seminar
6/3 Volkan Sevim, Ph.D.,IMO Post Doc Candidate, Modeling Cyclic Dynamics in Gene Regulatory Networks: Transcriptional Cell-Cycle Oscillator in Yeast
5/27 Keiran Smalley, Ph.D., Moffitt, BRAF Inhibition in Melanoma: From Response to Resistance
5/20 Eunjung Kim, Ph.D., IMO Post Doc Candidate, Mathematical Models for Matrix Mechanics and Cell-Matrix Interactions in Biological Systems
5/13 Eduardo Sotomayor, M.D., Moffitt, Targeting Histone Deacetylase 6 and 11 to Regulate Inflammation and Immune Tolerance
4/29 Craig Stevens, MD, Ph.D./Geoffrey Zhang, Ph.D., Moffitt, Deformable Image Registration and Pulmonary Ventilation Calculation Using 4D CT
4/22 Eric Haura, M.D., Moffitt, Expanding Drug And Biomarker Space Through Protein-Protein Interaction And Phosphoproteomic Networks
4/1 Virendra Kumar, Ph.D., Moffitt, Radiomics of Lung Cancer
4/1 Heather Cornnell, Ph.D., Moffitt, Measurement And Manipulation Of The Heterogeneity Of The Physical Tumor Microenvironment
4/1 Narges Kharazani Tafreshi, Ph.D., Moffitt, Indentification Of Novel Cell-Surface Targets Specific to Breast Cancer for the Non-invasive Detection of Metastatic Breast Cancer in Lymph Node
4/1 Jonathan Wojtkowski, Ph.D., Moffitt, Chronic Autophagy is a Cellular Adaptation to Tumor Acidic pH Microenvironment
3/11 Timothy J. Yeatman, M.D., Moffitt, Molecular Signatures Of Cancer
2/25 Channa de Silva, Ph.D., Department of Chemistry & Biochemistry and Bio5 Institute, University of Arizona, Images of Cleavage: Tumor Proteases In Action
2/04 Mark Robertson-Tessi, IMO Post Doc Candidate, A Mathematical Model of Tumor-Immune Interactions
1/21 Bakhti Vasiev, Ph.D., University of Liverpool, UK, Pattern Formation in Excitable Systems with Applications to Developmental Biology
2009
12/17 Dr. Jonathan Wojtkowiak, Moffitt, TBA
12/10 Dr. Philip Maini, Centre for Mathematical Biology, University of Oxford, Some mathematical models of Cancer growth
11/19 Dr. Philip Gerlee, Niels Bohr Institute, Denmark, TBA
11/16 (Monday) Dr. Peter Hinow, University of Wisconsin Milwaukee, Spatial Model of Tumor-Host Interaction: Application of Chemotherapy
11/12 Dr. Ingeborg van Leeuwen, Karolinska Insitute, Sweden, From mathematical modelling to cell biology: (1) A multiscale model for intestinal tissue renewal; and (2) The p53 pathway: complexity, oscillations, and therapeutic exploitation
11/11 (Wednesday) Dr. Carlo Maley, The Wistar Institute, TBA
10/20 (Tuesday) Dr. Kristin Swanson, University of Washington, Personalized Mathematical Oncology: Patient-Specific Mathematical Modeling of Glioma Growth and Progression
10/15 Dr. Juan Del Valle, Moffitt, Targeting Oncoproteins with Natural Product and Secondary Structure Mimetics
10/01 Dr. Robert Gatenby, Moffitt, New ideas for discussion: 1. Evolutionarily enlightened therapy 2. An ensemble model of intracellular pathways
9/17 Dr. James DeGregori, University of Colorado, Denver, Adaptive Oncogenesis: relating stem cell fittness, aging and cancer
9/10 Dr. Dmitry Gabrilovich, Moffitt, Regulation of immune responses in cancer by myeloid-derived suppressor cells
9/03 Dr. Said Sebti, Moffitt, Drug discovery at Moffitt: from chemical biology to hypothesis-driven clinical trials
8/27 Marco Scianna, Department of Mathematics, Politecnico di Torino, Italy, Individual Cell Based Models for Cell Scatter of ARO and MLP-29 Cells in Response to Hepatocyte Growth
8/27 Chiara Giverso, Department of Mathematics, Politecnico di Torino, Italy, Cellular Potts Model for Ovarian Cancer Metastasis
7/09 Dr. Scott Antonia, Moffitt, Immunotherapy Translational Research At Moffitt
7/10 Dr. Edward Flach, Dresden Technical University, Germany Motility and the cellular Potts model. Muscle development: slow twitch cell migration
6/04 Drs. Amanda Shanks, Yoonseok Kam, Ariosto Silva, Moffitt, IMO poster presentations
5/28 Dr. James Helm, Moffitt, Signaling Pathways and Outcomes in Pancreatic Cancer
5/21 Dr. Esteban Celis, Moffitt, Development of Optimized Epitope vaccines for Cancer
5/14 Dr. John Curd, Threshold Pharmaceuticals, Tumor hypoxia as a selective target for novel treatments in cancer-lessons from the development of TH-302
5/07 Dr. S. Sendhil Velan, West Virginia University, Department of Radiology, Localized Multi-DimensionalMRS: Unraveling the hidden resonances at clinical field strengths
4/30 Drs. Liping Xu, Kavindra Nath, David Basanta, Moffitt, IMO poster presentations
4/23 Dr. Gerold Bepler, Moffitt, RRM1 in lung cancer
4/24 Mr. Gibin Powathil, University of Waterloo, Canada, Modeling brain tumor: effects of microenvironment and associated therapeutic strategies
4/24 Mr. Cory Howk, Iowa State University, A mathematical model for IL6-induced differentiation of neural progenitor cells on a micropatterned polymer substrate
4/16 Dr. Jonathan Wojtkowiak, Moffitt, Autophagy: A matter of life and death
4/09 Drs. Gary V. Martinez, Arig Ibrahim Hashim, Prasanta Dutta, Moffitt, IMO poster presentations
4/02 Dr. P. K. Burnette, Moffitt, T cell homeostatsis in Bone Marrow Failure Syndromes
3/19 Dr. Virendra Kumar, Moffitt, Magnetic resonance spectroscopy and imaging in prostate cancer
3/12 Dr. Peter Thelwall, Newcastle University, UK, Imaging oxidative stress defences with MRI
3/05 Dr. Amanda Baker, University of Arizona, Thioredoxin-interacting protein as a potential target for pancreatic cancer therapy
2/26 Dr. Ed Seto, Moffitt, The Biology of Histone Deacetylases
2/19 Dr. Anna Giuliano, Moffitt, The Natural History of Human Papillomavirus Infection in Men
2/18 Dr. Emi Shudo, Los Alamos National Laboratory, Hepatatis C virus kinetics during treatment with pegylated interferon alfa-2b. A model that allows for time-varying drug effectiveness. & Dynamic optimization of the immune reaction against virus/bacteria infection
2/12 Dr. Yoonseok Kam, Moffitt, In vitro cancer migration-invasion assay design driven by mathematical models
2/05 Dr. Thomas Sellers, Moffitt, Approaches to determine ovarian cancer susceptibility
1/29 Samuel E. Day, University of Cambridge & NIH, DNP hyperpolarized 13C-MRI: an approach to study enzyme function using magnetic resonance spectroscopy and imaging
1/22 Dr. Eric Haura, Moffitt, Using shotgun phosphoproteomics to discern tyrosine kinase signaling in cancer
1/21 Dr. Hugo Aerts, University of Maastricht, Computer assisted theragnostics: an individualized decision support system
1/09 Natasha Kaleta Martin, University of Oxford, Biocarbonate therapy: from mice to humans with mathematical models
1/08 Dr. John Koomen, Moffitt, Cancer proteome cataloging and quantitative network analysis
2008
12/18 Dr. William Dalton, Moffitt, Novel targets to inhibit and reverse drug resistance in hematologic malignances
12/11 Dr. Javier Torres-Roca, Moffitt, System biology modeling of the radiosensitivity network
12/04 Dr. Ami Radunskaya, Pomona College, Mathematical models of tumor-immune interactions
11/20 Dr. David Morse, Moffitt, Choline as a biomarker for breast cancer diagnosis and therapeutic response
11/13 Dr. Simon Hayward, Vanderbilt University, Cellular interactions andprostate cancer progression
11/06 Dr. Keiran Smalley, Moffitt, Using 3D cell culture models to bring new insightsto cancer biology
10/30 Dr. Kasia Rejniak, Moffitt, IBCell model in cancer development andtreatment
10/23 Dr. Gerard Ostheimer, MIT, Data driven modeling of cellular senescence andapoptosis after DNA damage
10/16 Dr. Lori Hazlehurst, Moffitt, The bone marrow microenvironment contributestowards resistance to BCR-ABL inhibitors in CML
10/09 Dr. Philip Tofilon, Moffitt, The microenvironment and glioblastoma radiosensitivity
9/25 Dr. Alexander Anderson, Moffitt, Microenvironment driven invasion: a multiscale multimodel investigation
9/18 Dr. Robert Gilles, Moffitt, Acid-mediated invasion and bicarb treatment
9/11 Dr. David Basanta, Moffitt, Evolutionary game theory approaches to cancer modeling
9/04 Dr. Ariosto Silva, Moffitt, Adaptive therapy : an alternative cancer treatment